期刊
THORACIC SURGERY CLINICS
卷 23, 期 2, 页码 211-+出版社
W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.thorsurg.2013.01.002
关键词
Biomarkers; Genome sequencing; microRNA; Genomics; Proteomics; Epigenomics
The search for biomarkers in the management of lung cancer involves the use of multiple platforms to examine changes in gene, protein, and microRNA expression. Multiple studies have been published in an attempt to describe early detection, diagnostic, prognostic, and predictive biomarkers using chiefly tissues and blood elements. Studies are characterized by a lack of commonality of specific biomarkers, and a lack of validated, clinically useful markers. The future of biomarker discovery as a means of tailoring therapy for patients with lung cancer will involve next-generation sequencing along with collaborative efforts to integrate and validate candidate markers.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据